AMGN vs RVSB · P/E 24, rev $10.05B vs P/E 25, rev $15.3M
Amgen Inc (AMGN) versus Riverview Bancorp Inc (RVSB) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Riverview Bancorp Inc (RVSB) is a banks - regional company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported RVSB revenue for 2026-03-31 was $15.3M. Net income was -$8.0M. Revenue was up 5.5% from 2025-03-31 to 2026-03-31. RVSB currently screens at market cap $120.6M and trailing P/E 25.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. RVSB currently screens at market cap $120.6M and trailing P/E 25.0.
Not investment advice. Open the AMGN and RVSB stock pages for the full models.
Not investment advice.